Impact of organ-on-a-chip technology on pharmaceutical R&D costs

Franzen, Nora; van Harten, Wim H.; Retel, Valesca P.; Loskill, Peter; van den Eijnden-van Raaij, Janny; IJzerman, Maarten

dc.contributor.author	Loskill, Peter
dc.date.accessioned	2020-07-28T07:12:29Z
dc.date.available	2020-07-28T07:12:29Z
dc.date.issued	2019
dc.identifier.issn	1878-5832
dc.identifier.uri	http://hdl.handle.net/10900/103924
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.drudis.2019.06.003	de_DE
dc.subject.ddc	610	de_DE
dc.title	Impact of organ-on-a-chip technology on pharmaceutical R&D costs	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_01526
utue.publikation.seiten	1720-1724	de_DE
utue.personen.roh	Franzen, Nora
utue.personen.roh	van Harten, Wim H.
utue.personen.roh	Retel, Valesca P.
utue.personen.roh	Loskill, Peter
utue.personen.roh	van den Eijnden-van Raaij, Janny
utue.personen.roh	IJzerman, Maarten
dcterms.isPartOf.ZSTitelID	Drug Discovery Today	de_DE
dcterms.isPartOf.ZS-Issue	9	de_DE
dcterms.isPartOf.ZS-Volume	24	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE